Astra Limits Respiratory Drug's Development - Wall Street Journal
 FinanceNews.co.uk | Astra Limits Respiratory Drug's Development Wall Street Journal Motavizumab is being developed by Astra's US unit MedImmune to help prevent serious respiratory syncytial-virus infections, particularly in high-risk ... AstraZeneca takes $445m charge after lung disease drug disappointment AstraZeneca abandons motavizumab AstraZeneca suffers $445m hit over cancelled drug |
Source: news.google.com
Astra Microwave Products Fixes Record Date for Issue of 1:2 Bonus Shares - Equity Bulls
Astra Microwave Products Fixes Record Date for Issue of 1:2 Bonus Shares Equity Bulls Astra Microwave Products Ltd has announced that the Board of Directors of the Company at its meeting held on December 20, 2010 have fixed "December 31, ... |
Source: news.google.com
0 Responses to "Astra Limits Respiratory Drug's Development - Wall Street Journal (Duston VAUXHALL DEALERS)"
Post a Comment